Andreas Mackensen
Atmospheric Science · 2005–2022
A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Atmospheric Science — 14 citations into it
- Environmental Chemistry — 7 citations into it
Whom Andreas Mackensen trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- D. Lea (in Atmospheric Science)
Papers from Andreas Mackensen's perspective
Ordered by how strongly the researchers Andreas Mackensen trusts endorse each paper. Same corpus, a different order for every researcher.
- Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation (Journal of Experimental Medicine)
- Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade (Proceedings of the National Academy of Sciences of the United States of America)
- PD-L2 is a second ligand for PD-1 and inhibits T cell activation (Nature Immunology)
- Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity (Nature Medicine)
- SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation1 (Journal of Immunology)
- PD‐1:PD‐L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL‐2 (European Journal of Immunology)
- BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1 (Nature Immunology)
- PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine (Proceedings of the National Academy of Sciences of the United States of America)
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes (Science)
- PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells (Proceedings of the National Academy of Sciences of the United States of America)
Their papers
- Inhibitory effect of tumor cell-derived lactic acid on human T cells. (2007) — 1,805 citations
- Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus (2022) — 845 citations
- LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells. (2016) — 1,711 citations
- Deglaciation in the tropical Indian Ocean driven by interplay between the regional monsoon and global teleconnections (2013) — 172 citations
- Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. (2006) — 692 citations
- Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy (2005) — 621 citations